Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weiyong Li

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Oncology Letters|July 15, 2015
Upregulation of H19 promotes invasion and induces epithelial-to-mesenchymal transition in esophageal cancerCheng Huang, Lihua Cao, Limin Qiu, et al.
Scientific Reports|February 9, 2019
Chronic olanzapine administration causes metabolic syndrome through inflammatory cytokines in rodent models of insulin resistanceHuqun Li, Shiyong Peng, Shihong Li, et al.
Pharmacological Research|January 1, 2020
Resveratrol derivative excited postsynaptic potentiation specifically via PKCβ-NMDA receptor mediationJia Tong, Jingjing Gao, Qingzhen Liu, et al.
Oncotarget|July 9, 2014
The tumor suppressive role of CAMK2N1 in castration-resistant prostate cancerTao Wang, Zhuo Liu, Shuiming Guo, et al.
Nature Communications|May 6, 2016
miR-424(322) reverses chemoresistance via T-cell immune response activation by blocking the PD-L1 immune checkpointShaohua Xu, Zhen Tao, Bo Hai, et al.
Oncotarget|October 10, 2014
CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signalingTao Wang, Shuiming Guo, Zhuo Liu, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Oncology Letters|July 15, 2015
Upregulation of H19 promotes invasion and induces epithelial-to-mesenchymal transition in esophageal cancerCheng Huang, Lihua Cao, Limin Qiu, et al.
Scientific Reports|February 9, 2019
Chronic olanzapine administration causes metabolic syndrome through inflammatory cytokines in rodent models of insulin resistanceHuqun Li, Shiyong Peng, Shihong Li, et al.
Pharmacological Research|January 1, 2020
Resveratrol derivative excited postsynaptic potentiation specifically via PKCβ-NMDA receptor mediationJia Tong, Jingjing Gao, Qingzhen Liu, et al.
Oncotarget|July 9, 2014
The tumor suppressive role of CAMK2N1 in castration-resistant prostate cancerTao Wang, Zhuo Liu, Shuiming Guo, et al.
Nature Communications|May 6, 2016
miR-424(322) reverses chemoresistance via T-cell immune response activation by blocking the PD-L1 immune checkpointShaohua Xu, Zhen Tao, Bo Hai, et al.
Oncotarget|October 10, 2014
CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signalingTao Wang, Shuiming Guo, Zhuo Liu, et al.
Pageof 6